Literature DB >> 24306267

New evidence for roles of growth arrest-specific protein 6 (Gas6) in systemic lupus erythematosus.

Guo Tian1, Jiao-Long Li, Hai-Feng Pan, Dian Zhou.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24306267     DOI： 10.1007/s00296-013-2911-0

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN： 0172-8172            Impact factor:   2.631


× No keyword cloud information.
  11 in total

Review 1.  TAM receptor signaling and autoimmune disease.

Authors:  Carla V Rothlin; Greg Lemke
Journal:  Curr Opin Immunol       Date:  2010-10-26       Impact factor: 7.486

2.  Elevated serum level of growth arrest-specific protein 6 (Gas6) in systemic lupus erythematosus patients is associated with nephritis and cutaneous vasculitis.

Authors:  Chien-Sheng Wu; Chung-Yi Hu; Hwei-Fang Tsai; I-Tsu Chyuan; Cheng-Ju Chan; Sheng-Kai Chang; Ping-Ning Hsu
Journal:  Rheumatol Int       Date:  2013-11-01       Impact factor: 2.631

3.  Efficient clearance of early apoptotic cells by human macrophages requires M2c polarization and MerTK induction.

Authors:  Gaetano Zizzo; Brendan A Hilliard; Marc Monestier; Philip L Cohen
Journal:  J Immunol       Date:  2012-08-31       Impact factor: 5.422

4.  Decreased serum level of IL-21 in new-onset systemic lupus erythematosus patients.

Authors:  Hai-Feng Pan; Guo-Cui Wu; Yin-Guang Fan; Rui-Xue Leng; Hui Peng; Mo Zhou; Bao-Zhu Li; Yan Zhu; Jin-Hui Tao; Xiang-Pei Li; Dong-Qing Ye
Journal:  Rheumatol Int       Date:  2013-03-29       Impact factor: 2.631

5.  TAM receptor ligands in lupus: protein S but not Gas6 levels reflect disease activity in systemic lupus erythematosus.

Authors:  Chang-Hee Suh; Brendan Hilliard; Sophia Li; Joan T Merrill; Philip L Cohen
Journal:  Arthritis Res Ther       Date:  2010-07-16       Impact factor: 5.156

6.  Serum growth arrest-specific protein 6 levels are a reliable biomarker of disease activity in systemic lupus erythematosus.

Authors:  Hyoun-Ah Kim; Jin-Young Nam; Ja-Young Jeon; Jeong-Mi An; Ju-Yang Jung; Chang-Bum Bae; Chang-Hee Suh
Journal:  J Clin Immunol       Date:  2012-08-23       Impact factor: 8.317

7.  Plasma concentrations of growth arrest specific protein 6 and the soluble form of its tyrosine kinase receptor Axl in patients with systemic lupus erythematosus and Behçets disease.

Authors:  Tamer A Gheita; Iman H Bassyouni; Rasha H Bassyouni
Journal:  J Clin Immunol       Date:  2012-07-26       Impact factor: 8.317

8.  Growth arrest specific protein 6/Axl signaling in human inflammatory renal diseases.

Authors:  Anette Fiebeler; Joon-Keun Park; Dominik N Muller; Carsten Lindschau; Michael Mengel; Saskia Merkel; Bernhard Banas; Friedrich C Luft; Hermann Haller
Journal:  Am J Kidney Dis       Date:  2004-02       Impact factor: 8.860

9.  Plasma concentrations of Gas6 and sAxl correlate with disease activity in systemic lupus erythematosus.

Authors:  Carl Ekman; Andreas Jönsen; Gunnar Sturfelt; Anders A Bengtsson; Björn Dahlbäck
Journal:  Rheumatology (Oxford)       Date:  2011-01-28       Impact factor: 7.580

10.  Vitamin K-dependent proteins GAS6 and Protein S and TAM receptors in patients of systemic lupus erythematosus: correlation with common genetic variants and disease activity.

Authors:  Pedro Recarte-Pelz; Dolors Tàssies; Gerard Espinosa; Begoña Hurtado; Núria Sala; Ricard Cervera; Joan Carles Reverter; Pablo García de Frutos
Journal:  Arthritis Res Ther       Date:  2013-03-12       Impact factor: 5.156
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.